Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2011-07-14 M&A Activity
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Orexo takes leading position in diagnostic breath tests through acquisition
M&A Activity Classification · 1% confidence The document is explicitly labeled as a "Press release" dated July 14, 2011, announcing the acquisition of Wagner Analysen Technik GmbH by Orexo's subsidiary Kibion AB. This announcement details a significant corporate transaction (M&A activity) and includes related management changes (appointment of Henrik Juuel to Kibion's Board). While it involves management changes (MANG) and financing (CAP, as the purchase price is mentioned), the primary corporate action being announced is the acquisition itself. The closest fit among the provided codes for a major corporate transaction announcement like an acquisition/takeover proposal is 'M&A Activity' (TAR). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS), but rather the substance of the news itself.
2011-07-14 English
Major Shareholding Notification 2011
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific holder ('HealthCap 99 KB') in the issuer ('Orexo AB'). It explicitly mentions 'Reason for major shareholding notification New share issue' and provides the 'Before the transaction' and 'After the transaction' share counts and resulting percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized as 'MRQ' in the provided schema.
2011-06-30 English
Orexo announces successful completion of rights issue providing gross proceeds of about SEK 250 million
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated June 29, 2011, announcing the 'successful completion of rights issue providing gross proceeds of about SEK 245 million.' A rights issue is a form of capital fundraising or financing activity. This directly aligns with the definition for Capital/Financing Update (CAP). Although it is a press release, the core subject matter is the financing event itself, not just the announcement of a report (which would suggest RPA or RNS). Since CAP is a specific category for financing activities, it is preferred over the general RNS fallback.
2011-06-29 English
Orexos meddelar framgångsrikt avslutad nyemission om cirka 245 MSEK
Share Issue/Capital Change Classification · 1% confidence The document is explicitly titled as a "Pressmeddelande" (Press Release) dated June 29, 2011, announcing the successful completion of a rights issue ('nyemission') raising approximately 245 MSEK. This action directly relates to fundraising, financing activities, and capital structure changes. Based on the provided definitions, the most appropriate category is 'Capital/Financing Update' (CAP). Although it is a press release, the core content is the financing event itself, not just an announcement of a report's publication (RPA/RNS). The document length is short (3450 chars), but the content is substantive regarding the capital raise, making CAP a better fit than RPA.
2011-06-29 Swedish
Orexo announces addendum to prospectus made public
Capital/Financing Update Classification · 1% confidence The document is a press release dated June 15, 2011, titled "Orexo announces addendum to prospectus made public." It explicitly discusses a 'Rights Issue' and directs readers to a link for more information about the rights issue and prospectus. The text is short (3021 characters) and functions as an announcement regarding the availability or update of a formal document (the prospectus/rights offering details), rather than being the full prospectus or a comprehensive financial report. This aligns best with the definition of a Report Publication Announcement (RPA), which covers announcements about the release or publication of company reports, or potentially a Capital/Financing Update (CAP) due to the focus on a Rights Issue. Given the explicit mention of announcing the addendum to the prospectus and providing contact/disclaimer information typical of a brief market announcement, RPA is the most precise fit based on the 'MENU VS MEAL' rule, as it is announcing the availability of the underlying financing document.
2011-06-15 English
Orexo offentliggör tilläggsprospekt
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "Pressmeddelande" (Press Release) and announces that Orexo is publishing a supplement to the prospectus regarding a new share issue ("nyemission"). The core action is the publication of a document related to financing/capital structure (the prospectus supplement). Since the document itself is a short announcement (2917 chars) stating that the prospectus supplement is available elsewhere (on the website or at the office), it fits the criteria for a Report Publication Announcement (RPA) or a Capital/Financing Update (CAP). Given the specific nature of announcing the availability of a prospectus supplement related to a share issue, 'CAP' (Capital/Financing Update) is highly relevant, but the 'MENU VS MEAL' rule suggests that an announcement about a document's availability leans towards RPA. However, the content is fundamentally about a capital action (new share issue). Comparing CAP and RPA: CAP covers fundraising/financing activities. RPA covers the announcement of report publication. Since this is an announcement *about* a financing document (prospectus supplement), both are plausible. Given the strong focus on the 'nyemission' (new share issue), CAP is the most specific fit for the underlying corporate action being communicated, even if it's delivered as a publication announcement. I will classify it as CAP because the subject matter is financing, which is more specific than just announcing a publication.
2011-06-15 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.